|
|
||||||||
From the Department of Ophthalmology, the Guys, Kings and St. Thomas Hospitals Medical and Dental School, Kings College London, United Kingdom.
PURPOSE. To characterize and determine the effect of aging on the matrix metalloproteinase (MMP) component of the extracellular matrixremodeling mechanism of isolated human Bruchschoroid.
METHODS. Immunohistochemical techniques and western blot analysis were used to detect and localize various members of the MMP family of proteolytic enzymes in the Bruchschoroid complex. Gelatin substrate zymography was used to detect and quantify the levels of MMP-2 and -9 in homogenates of Bruchschoroid from both macular and peripheral regions of the human fundus. Aging alterations in these enzymes were quantified by densitometric analysis of photographic negatives of the zymography gels.
RESULTS. Intact preparations of Bruchschoroid showed the presence of inactive forms of two gelatinases (MMP-2, 65 kDa, and MMP-9, 92 kDa), interstitial collagenase (MMP-1, 52 kDa) and stromelysin (MMP-3, 57 kDa). MMP-1 and -3 were localized primarily to Bruchs membrane. MMP-9 was distributed evenly in Bruchs membrane with some patchy presence in the choroidal mass. Distribution of MMP-2 was similar to that of MMP-9, but the staining in Bruchs was much fainter. On gelatin zymography, an active form of MMP-2 (58-kDa species) was frequently observed in peripheral samples but only occasionally in macular regions. The levels of MMP-2 and -9 increased with aging in both the macular and the peripheral regions of the fundus (P < 0.05). MMP-2 levels were lower in macular regions than in the periphery but no such variation was observed with MMP-9. Both these inactive gelatinases could be activated in vitro.
CONCLUSIONS. A matrix-degrading mechanism essential for extracellular remodeling was shown to be present in Bruchs membrane. In macular regions, increasing levels of inactive forms of metalloproteinase and scarcity of active forms of MMP-2 suggests possible involvement of impaired extracellular degradation in both aging and macular degeneration.
This article has been cited by other articles:
![]() |
H. G. Yu, X. Liu, S. Kiss, E. Connolly, E. S. Gragoudas, N. A. Michaud, O. V. Bulgakov, M. Adamian, M. M. DeAngelis, J. W. Miller, et al. Increased Choroidal Neovascularization following Laser Induction in Mice Lacking Lysyl Oxidase-like 1 Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2599 - 2605. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Tatar, A. Adam, K. Shinoda, T. Eckert, G. B Scharioth, M. Klein, E. Yoeruek, K. U. Bartz-Schmidt, and S. Grisanti Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy Br. J. Ophthalmol., September 1, 2007; 91(9): 1183 - 1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Ugarte, A A Hussain, and J Marshall An experimental study of the elastic properties of the human Bruch's membrane-choroid complex: relevance to ageing Br. J. Ophthalmol., May 1, 2006; 90(5): 621 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Amin, N. H. V. Chong, T. A. Bailey, J. Zhang, C. Knupp, M. E. Cheetham, J. Greenwood, and P. J. Luthert Modulation of Sub-RPE Deposits In Vitro: A Potential Model for Age-Related Macular Degeneration Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1281 - 1288. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Bhutto, S. Y. Kim, D. S. McLeod, C. Merges, N. Fukai, B. R. Olsen, and G. A. Lutty Localization of Collagen XVIII and the Endostatin Portion of Collagen XVIII in Aged Human Control Eyes and Eyes with Age-Related Macular Degeneration Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1544 - 1552. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Zarbin Current Concepts in the Pathogenesis of Age-Related Macular Degeneration Arch Ophthalmol, April 1, 2004; 122(4): 598 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Ruberti, C. A. Curcio, C. L. Millican, B. P. M. Menco, J.-D. Huang, and M. Johnson Quick-Freeze/Deep-Etch Visualization of Age-Related Lipid Accumulation in Bruch's Membrane Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1753 - 1759. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Eichler, U. Friedrichs, A. Thies, C. Tratz, and P. Wiedemann Modulation of Matrix Metalloproteinase and TIMP-1 Expression by Cytokines in Human RPE Cells Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2767 - 2773. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ahir, L. Guo, A. A. Hussain, and J. Marshall Expression of Metalloproteinases from Human Retinal Pigment Epithelial Cells and Their Effects on the Hydraulic Conductivity of Bruch's Membrane Invest. Ophthalmol. Vis. Sci., February 1, 2002; 43(2): 458 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. VaughanThomas, S. J. Gilbert, and V. C. Duance Elevated Levels of Proteolytic Enzymes in the Aging Human Vitreous Invest. Ophthalmol. Vis. Sci., October 1, 2000; 41(11): 3299 - 3304. [Abstract] [Full Text] |
||||
![]() |
J. Salzmann, G A. Limb, P. T Khaw, Z. J Gregor, L. Webster, A. H Chignell, and D. G Charteris Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy Br. J. Ophthalmol., October 1, 2000; 84(10): 1091 - 1096. [Abstract] [Full Text] |
||||
![]() |
C S SETHI, T A BAILEY, P J LUTHERT, and N H V CHONG Matrix metalloproteinase biology applied to vitreoretinal disorders Br. J. Ophthalmol., June 1, 2000; 84(6): 654 - 666. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |